This phenomenon is caused by an up till now

unknown mechanism and should be evaluated by biochemical measurement studies in the near future. Considering body mass index, our results show, in accordance with previous studies, a strong association between high body mass index and low vitamin D levels [24]. This supports the hypothesis that an increase of body mass index leads to a larger distribution volume in the body for the selleck chemicals fat-soluble vitamin D which lowers the serum 25OHD concentration. Vitamin D supplementation In our study population, oral vitamin D supplementation is significantly associated with a decreased risk of vitamin D deficiency in summer (p  =  0.029) CFTRinh-172 clinical trial and winter (p  <  0.001). Nevertheless, the effects of vitamin D supplementation are far from satisfactory with the generally low dosages used in this study, where daily intake check details does not exceed 200–400 IU/day.

At the end of summer, 30% of the patients using supplementation were still vitamin D deficient. At the end of winter, even 44% of the vitamin D supplemented patients had serum 25OHD <50 nmol/L. The fact that only a non-significant trend and not a significant relation could be observed between higher dosages and serum 25OHD levels is probably caused by the low dosages of vitamin D supplementation in this study population. This year, Jørgensen et al. published one of the first randomized placebo-controlled trials among 108 CD patients to assess the effects of 1,200 IU cholecalciferol daily on CD activity [25]. The investigators concluded that these vitamin D dosages decreased disease activity and, more importantly, were safe to use. Fossariinae With regard to fracture risk reduction, various meta-analyses reported a decrease of fracture risk of 13% to 26% with 700–800 IU vitamin D daily [26]. In contrast to the general consensus, Sanders et al. recently reported that one annual mega dosage of 600,000 IU cholecalciferol

caused an increase of falls and fractures among 2,256 postmenopausal women [27]. Although the biological mechanisms of these findings are unclear, they indicate that the dosing regimen of cholecalciferol is important, and infrequent extreme doses are counterproductive in decreasing fracture risk. Taking the existing evidence into account, it is without doubt of major importance to prevent bone fractures by vitamin D supplementation which is frequently administered (i.e. daily, weekly or monthly). Although the optimal vitamin D supplementation dosages remain unclear, various authors state that the currently prescribed dosages are generally too low and can be raised up to 4,000 IU/day without any adverse effects [25, 28–31]. Our results on vitamin D supplementation support the need of further studies for optimal vitamin D dosages in the general population and specifically for the IBD subgroup.